February 21, 2017
TSRI-Invented Compound Ozanimod Shows Positive Results in Late-Stage Clinical Trial for Relapsing Multiple Sclerosis
Results from a new Phase 3 study conducted by the Celgene Corporation demonstrate that ozanimod, a drug candidate originally discovered and optimized at The Scripps Research Institute (TSRI), can reduce the frequency of multiple sclerosis relapse.
February 21, 2017
The Scripps Research Institute Announces New Board Members and Chairman of the Board
The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, today announced the appointment of nine new members to its Board of Directors, including John D. Diekman, who will serve as chairman of the board.
February 13, 2017
TSRI Researchers Discover How the Brain Turns Chronic Stress into Pathological Anxiety
Researchers at The Scripps Research Institute (TSRI) have described the role of two important molecules in the brain that work together to trigger intense anxiety
February 02, 2017
TSRI Chemists Unveil Versatile New Method for Making Chiral Drug Molecules
“This method essentially mimics the ability of the enzymes in our cells to turn simple organic molecules into chiral molecules,” said senior author Jin-Quan Yu, Frank and Bertha Hupp Professor in the Department of Chemistry at TSRI.
February 01, 2017
TSRI Scientists Show Deep Brain Stimulation Blocks Heroin Relapse in Rats
Scientists at The Scripps Research Institute (TSRI) have found that deep brain stimulation (DBS) can greatly reduce the compulsion to use heroin in standard rat models of addiction.
January 30, 2017
New TSRI Study Shows Early Brain Changes in Fragile X Syndrome
A new study led by scientists at The Scripps Research Institute (TSRI) is giving researchers a first look at the early stages of brain development in patients with Fragile X syndrome, a disorder that causes mild to severe intellectual disability and is the most common genetic cause of autism spectrum disorder.
January 27, 2017
TSRI Scientists Find Brain Hormone that Triggers Fat Burning
Biologists at The Scripps Research Institute (TSRI) have identified a brain hormone that appears to trigger fat burning in the gut.
January 23, 2017
TSRI Scientists Create First Stable Semisynthetic Organism
Scientists at The Scripps Research Institute (TSRI) have announced the development of the first stable semisynthetic organism.
January 19, 2017
New TSRI Method Could Turbocharge Drug Discovery, Protein Research
A team led by scientists at The Scripps Research Institute (TSRI) has developed a versatile new method that should enhance the discovery of new drugs and the study of proteins.
January 12, 2017
TSRI Scientists Discover Master Regulator of Cellular Aging
Scientists at The Scripps Research Institute (TSRI) have discovered a protein that fine-tunes the cellular clock involved in aging.
January 10, 2017
The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology
The Scripps Research Institute (TSRI), a leading non-profit biomedical research institute, today announced a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to pioneer new DNA-encoded library (DEL) technology, including new synthetic chemistry for the creation of next-generation DELs, a potentially transformative technology for early stage drug discovery research.
January 09, 2017
Intarcia and Calibr Announce Collaboration and In-Licensing Deal Aimed At Delivering a Next Generation Combination Product For Diabetes & Obesity
Calibr News: Calibr, a corporate affiliate of The Scripps Research Institute, has announced a strategic research collaboration with Intarcia Therapeutics, Inc.
January 03, 2017
TSRI Scientists Take Step Toward Mapping How the Brain Stores Memories
The research, published recently in the journal eLife, is the first to demonstrate that the same brain region can both motivate a learned behavior and suppress that same behavior.